As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO), the WHO Regional Office for Africa (AFRO), and the WHO Country Office (PO) in the Republic of Congo provided technical assistance to support the Directorate of Pharmacy and Medicine (DPM) of Congo from February 15 to 19 2021 in Brazzaville (Republic of Congo).

The Global Benchmarking Tool (GBT) integrates the Maturity Level (ML) of the various drug regulatory functions in a computerized platform that facilitates its use and the ranking of maturity indicators. This self-assessment has enabled several countries in the sub-region to identify their ML as well as to put in place institutional development plans (IDPs) in order to access a ML which guarantees safety,  quality and effectiveness of drugs in development and in circulation.

Click here to for news release in English.

Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Driving Global Health innovation: the IMVACS annual meeting in Lecce and R-Evolution Worldwide’s partnership with UniSalento

This year Lecce served as the host city for the Annual Meeting of our coordinated project IMVACS (Building multidisciplinary evidence to support Integrating Malaria VACcine with Seasonal malaria chemoprevention in

Read More

AfriNEXT

AfriNEXT project aims to develop and promote a vibrant, strong and sustainable research culture Africa. The project will create a critical mass of African world-class researchers capable of carrying out

Read More

Driving Impact and Collaboration: NeuroSolve 2026 Annual Meeting in Morogoro

On the last 30th and 31st of May, R-Evolution Worldwide lead the second Annual Meeting of NeuroSolve, our coordinated project aiming to address the burden of neurocysticercosis and improve the

Read More